中金发表报告指,药明生物(02269.HK) 公布,爱尔兰疫苗工厂与默沙东达成协议,默沙东将收购药明海德在爱尔兰的疫苗工厂,总交易金额约为5亿美元。公司预计本次交易将在上半年满足惯例交割条件完成。中金认为本次交易对报表端影响有限。本次交易对象为药明海德位于爱尔兰的疫苗工厂,药明海德 2023年收入和净利润分别为9.83亿元和3,830万元人民币,净利润占全公司比例为1.1%。本次交易总金额为5...
Source Link中金发表报告指,药明生物(02269.HK) 公布,爱尔兰疫苗工厂与默沙东达成协议,默沙东将收购药明海德在爱尔兰的疫苗工厂,总交易金额约为5亿美元。公司预计本次交易将在上半年满足惯例交割条件完成。中金认为本次交易对报表端影响有限。本次交易对象为药明海德位于爱尔兰的疫苗工厂,药明海德 2023年收入和净利润分别为9.83亿元和3,830万元人民币,净利润占全公司比例为1.1%。本次交易总金额为5...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.